Back to results
Unknown

SGLT2 Inhibitors and Reducing the Risk of Cancers Among Diabetics , an Observational Study

NCT05612269

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

ministry of health , First health cluster , Riaydh

Riyadh, N/A (Non-US), Saudi Arabia

View on ClinicalTrials.gov
SGLT2 Inhibitors and Reducing the Risk of Cancers Among Diabetics , an Observational Study — TrialFind